Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Assets
Loans receivable	$ 72,596,149	$ 73,048,403
Interest receivable on loans	1,514,836	1,395,905
Cash	87,097	104,222
Cash - restricted	311,545	1,587,773
Other assets	97,734	63,636
Operating lease right-of-use asset, net	193,650	207,364
Deferred financing costs, net	24,400	27,583
Total assets	74,825,411	76,434,886
Liabilities:
Line of credit	23,450,677	25,152,338
Senior secured notes (net of deferred financing costs of $153,298 and $172,069, respectively)	5,846,702	5,827,931
Deferred origination fees	655,023	719,019
Accounts payable and accrued expenses	263,692	295,292
Operating lease liability	206,934	220,527
Dividends payable	1,315,445	1,287,073
Total liabilities	31,738,473	33,502,180
Commitments and contingencies
Stockholders’ equity:
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,438,651 and 11,440,651 outstanding, respectively	11,757	11,757
Additional paid-in capital	45,552,142	45,548,876
Less: Treasury stock, at cost – 318,407 and 316,407 shares	(1,070,406)	(1,060,606)
Accumulated deficit	(1,406,555)	(1,567,321)
Total stockholders’ equity	43,086,938	42,932,706
Total liabilities and stockholders’ equity	$ 74,825,411	$ 76,434,886